|
Malaria is a preventable and cureable disease, although
resistance to all available forms of treatment has emerged in some
instances.
There were an estimated 881 000 (610 000–1 212 000)
malaria deaths in 2006, of which 91% (801 000, range 520 000–1 126 000)
were in Africa and 85% were of children under 5 years of age.
Eighty-six percent, or 212 million (with the wide
uncertainy range of 152–287 million) cases, were in the African Region.
While some countries in Africa have achieved a 50%
reduction in malaria cases since 2000, links between interventions and
mortality and morbidity trends remain ambiguous in that region and
elsewhere.
Access to malaria treatment, especially artemisinin-based
combination therapy, was inadequate in all countries surveyed in 2006,
despite a sharp increase in procurement of antimalarial medicines through
public health services.
The WHO recommended focus for prevention and control is
with long-lasting insecticidal nets (LLINs) and artemisinin-based
combination therapy (ACT), plus a revival of support for indoor residual
spraying of insecticide (IRS). Resistance to preferred insecticides for
vector control is a huge challenge.
|